Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 40.89
+1.02 (2.56%)
Mar 6, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 6.5 billion as of March 6, 2026. Its market cap has increased by 74.00% in one year.
Market Cap
6.50B
Enterprise Value
6.15B
Revenue
871.31M
Ranking
n/a
PE Ratio
112.45
Stock Price
40.89
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 6.50B, an increase of 15.94%. That is a compound annual growth rate of 1.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.50B | 2.87% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 7.18B |
| Jiangsu Aidea Pharmaceutical Group | 7.15B |
| Shenzhen Weiguang Biological Products | 6.57B |
| R&G PharmaStudies | 6.26B |
| Lifecome Biochemistry | 6.23B |
| Xiangxue Pharmaceutical | 6.08B |
| GemPharmatech | 6.05B |
| Shanghai OPM Biosciences | 5.88B |